What exactly is Zimeta and why would a vet reach for it?

Zimeta is the brand name for an injectable formulation of dipyrone (metamizole), a nonsteroidal anti-inflammatory drug in the pyrazolone chemical class. It received FDA approval in January 2021 as the first and, as of this writing, only pyrazolone-class NSAID cleared specifically for control of fever in horses, manufactured by Bimeda under New Animal Drug Application review (U.S. Food and Drug Administration, 2021). Unlike oral NSAIDs a horse owner might give at home, Zimeta is labeled for intravenous administration only, meaning it has to be injected directly into the bloodstream by a veterinarian rather than handed out for barn use.

The drug's job is narrow and specific: it lowers body temperature and eases the discomfort that comes with it. It does not treat the virus, bacteria, or inflammatory disease driving the fever in the first place. The American Association of Equine Practitioners notes that fever-reducing therapy is generally paired with diagnostics and, when appropriate, disease-specific treatment such as antimicrobials, rather than used as a standalone fix (American Association of Equine Practitioners, 2022).

What actually causes a fever high enough to need this kind of injection?

Fever in horses most often traces back to respiratory disease — equine influenza, equine herpesvirus, and bacterial pathogens like Streptococcus equi (strangles) are frequent culprits, particularly in horses that travel to shows, sales, or boarding facilities where they mix with unfamiliar animals (Merck Veterinary Manual, 2023). A normal adult horse's resting temperature runs roughly 99 to 101.5°F, and anything sustained above that range prompts most vets to start looking for an infectious or inflammatory trigger.

Fever can also accompany less obvious problems: abscesses, colitis, peritonitis, or reactions to recent vaccination or transport stress. Because the list of possible causes is long, a veterinarian typically pulls blood work, checks for nasal discharge or lymph node swelling, and may run a fibrinogen or complete blood count before deciding a fever-reducing drug like Zimeta is warranted rather than just treating blindly (Equine Guelph, 2023).

How is Zimeta actually given, and how much does a horse get?

Zimeta comes as a 500 mg/mL dipyrone solution given as a single slow intravenous injection, with the label dose calculated by the horse's body weight — this is not a drug an owner draws up and administers themselves. Because it's IV-only, the veterinarian remains on-site or nearby to monitor the horse during and immediately after dosing (U.S. Food and Drug Administration, 2021).

If fever persists, a vet may repeat dosing according to label directions, but repeated use is capped within a set window rather than given indefinitely, and the vet reassesses the underlying condition between doses rather than simply re-medicating on a fixed schedule (American Association of Equine Practitioners, 2022).

What side effects or reactions should I watch for afterward?

As with other injectable NSAIDs, the most commonly reported issues involve the injection site itself — mild swelling, heat, or tenderness where the needle entered the vein. Because dipyrone works partly through prostaglandin inhibition, gastrointestinal upset (reduced appetite, soft manure, or mild colic-like discomfort) is the category vets watch most closely, consistent with the broader NSAID class in horses (Merck Veterinary Manual, 2023).

Rare but more serious reactions reported with pyrazolone-class drugs in various species include blood dyscrasias affecting white blood cell counts, which is part of why Zimeta is restricted to veterinary administration with monitoring rather than sold for owner use at home (U.S. Food and Drug Administration, 2021). Horses with pre-existing kidney or GI disease are generally considered higher risk for NSAID-related complications of any kind.

How does Zimeta compare to older fever reducers like flunixin or phenylbutazone?

Flunixin meglumine (commonly known by the brand Banamine) and phenylbutazone have been used in horses for decades and both reduce fever as a secondary effect of their broader anti-inflammatory and pain-relieving action. Zimeta's pyrazolone chemistry works through a different mechanism and was studied specifically for its fever-control profile, which is why the FDA approval is narrower — labeled for fever, not general pain or lameness, unlike bute or flunixin (U.S. Food and Drug Administration, 2021).

Vets sometimes choose Zimeta over older NSAIDs in horses where a more targeted, shorter-acting antipyretic is preferred, or where a horse has already received another NSAID and stacking drugs from the same broader class raises GI or kidney risk. The American Association of Equine Practitioners cautions against combining multiple NSAIDs concurrently regardless of which specific drugs are involved, since the ulcer and kidney injury risk compounds (American Association of Equine Practitioners, 2022).

Are there horses that shouldn't receive Zimeta at all?

Horses with known hypersensitivity to pyrazolone derivatives are the clearest contraindication, and the FDA approval documentation flags this as a labeled warning (U.S. Food and Drug Administration, 2021). Horses with significant dehydration, existing kidney impairment, or active gastrointestinal ulceration are generally considered poor candidates for any NSAID, including Zimeta, until those issues are addressed or the vet weighs the risk-benefit specifically.

Pregnant or breeding animals and foals also warrant extra caution, since safety data in those populations is more limited than in mature, non-breeding horses — something a veterinarian factors in before recommending the drug for a fever in a broodmare or young horse (Merck Veterinary Manual, 2023).

How fast does it work and how long does the fever-lowering effect last?

Because Zimeta is given intravenously, its onset is fast relative to oral medications, with vets typically checking temperature again within a few hours of dosing to gauge response. The labeled duration of effect informs how vets space repeat doses, generally allowing a set number of hours to pass before considering another injection rather than re-dosing at the first sign the fever ticks back up (U.S. Food and Drug Administration, 2021).

A horse that doesn't respond to Zimeta, or whose fever breaks and then spikes again shortly after, usually needs the underlying diagnosis revisited — a persistent or recurring fever despite antipyretic treatment is itself a clinical clue that points toward a more serious or unresolved infectious process (Merck Veterinary Manual, 2023).

What follow-up care does my horse need in the hours and days after treatment?

After a Zimeta injection, most vets recommend rechecking rectal temperature every few hours, monitoring appetite and manure output, and watching the injection site for swelling or heat. Since the drug masks fever without treating the cause, isolation from other horses is often still recommended if an infectious respiratory disease like strangles or influenza is suspected, since a horse can remain contagious even after its temperature normalizes (Merck Veterinary Manual, 2023).

Feed and water intake should be tracked closely for 24 to 48 hours, since NSAID use of any kind raises the index of suspicion for GI upset. Owners are generally asked to report any drop in manure output, signs of colic, or return of fever promptly so the vet can reassess rather than waiting out the next scheduled recheck (American Association of Equine Practitioners, 2022).